In TB-T2DM, elevated ROS accelerates GSH oxidation to GSSG, resulting in feedback inhibition on GCL and promoting GSH synthesis from glycine, cysteine, and glutamate (Lu, 2013). The gene discussed is GCLC; the disease is type 2 diabetes mellitus.